Roche skin cancer drug to get priority review in U.S.

by on Nov.09, 2011, under Health and Fitness

Roche's experimental skin cancer drug vismodegib has been given "priority review" status by U.S. authorities, the Swiss drugmaker said on Wednesday.

Howdy. Welcome to Vision Eyecare Lasik Health and Medical News/Updates!
Thanks for dropping by! Feel free to join the discussion by leaving comments, and stay updated by subscribing to the RSS feed. See ya around!
May 2012

M T W T F S S

« Apr

1 2 3 4 5 6

7 8 9 10 11 12 13

14 15 16 17 18 19 20

21 22 23 24 25 26 27

28 29 30 31

Use the form below to search the site:

Still not finding what you're looking for? Drop a comment on a post or contact us so we can take care of it!

A few highly recommended friends...

Vision Eyecare Lasik Health and Medical News/Updates